https://www.selleckchem.com/pr....oducts/pf-477736.htm
s cytomembranes, cell cycle, and adipocytokine signaling. We successfully developed a GS based on genome-wide network, which may represent a novel prognostic factor for GC. A combination of GS and TNM staging provides additional precision in stratifying patients with different OS prognoses, constituting a more comprehensive sub-typing system. This could potentially play an important role in future clinical practice. We successfully developed a GS based on genome-wide network, which may represent a novel prognostic factor for GC. A com